Advancement of Technology for Precision Medicine

Author(s): Bing Niu

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 40 , 2019

Become EABM
Become Reviewer

[1]
Chou KC. An insightful 10-year recollection since the emergence of the 5-steps rule. Curr Pharm Des 2019; 25(40): 4223-34.
[2]
Dong Y, Qu X, Wu G, et al. Advances in the detection, mechanism and therapy studies of chronic kidney disease. Curr Pharm Des 2019; 25(40): 4235-50.
[3]
Zhang Y, Liu Z. Oncolytic virotherapy for malignant tumor: current clinical status. Curr Pharm Des 2019; 25(40): 4251-63.
[4]
Zhou G, Zhao M, Liang R, et al. Study of mechanism on binding between neratinib and MAD2L1 based on molecule simulation and multi-spectroscopy methods. Curr Pharm Des 2019; 25(40): 4287-95.
[5]
Zhang D, Guan Z-X, Zhang Z-M, et al. Recent development of computational predicting bioluminescent proteins. Curr Pharm Des 2019; 25(40): 4264-73.
[6]
Zhang Y, Han Z, Gao Q, Bai X, Zhang C, Hou H. Prediction of K562 cells functional inhibitors based on machine learning approaches. Curr Pharm Des 2019; 25(40): 4296-302.
[7]
Zheng H, Zeng Z, Wen H, et al. Application of genome-wide association analysis in the study of coronary artery disease. Curr Pharm Des 2019; 25(40): 4274-86.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 40
Year: 2019
Page: [4221 - 4222]
Pages: 2
DOI: 10.2174/138161282540191230093056

Article Metrics

PDF: 17
HTML: 4
PRC: 1